Highlights

  • The Lancet: Mixing other vaccines better than two doses of Pfizer or AstraZeneca
  • Study conducted by team of researchers at University of Oxford
  • Study crucial to help rapidly deploy these vaccines amid Omicron fears

Latest news

Asus Zenbook S 16 Review: Premium features for premium price?  Check specs, price, pros and cons

Asus Zenbook S 16 Review: Premium features for premium price?  Check specs, price, pros and cons

Prospects of economy expected to improve in 2025: RBI Governor

Prospects of economy expected to improve in 2025: RBI Governor

Biden announces $2.5 billion in fresh military aid to Ukraine

Biden announces $2.5 billion in fresh military aid to Ukraine

Rohit Sharma reflects on India’s disappointing loss to Australia in MCG Test

Rohit Sharma reflects on India’s disappointing loss to Australia in MCG Test

AAP govt will give temple, gurdwara priest Rs 18,000 a month if returns to power: Arvind Kejriwal

AAP govt will give temple, gurdwara priest Rs 18,000 a month if returns to power: Arvind Kejriwal

India’s housing market in de-growth phase, pins hopes on Budget

India’s housing market in de-growth phase, pins hopes on Budget

Indian sports in 2024: A year of triumphs, milestones, and narrow defeats

Indian sports in 2024: A year of triumphs, milestones, and narrow defeats

Crashed jetliner was 'shot down' by Russia unintentionally: Azerbaijan president

Crashed jetliner was 'shot down' by Russia unintentionally: Azerbaijan president

Mixing vaccines with AstraZeneca, Pfizer induces strong immune response: Lancet study

A team led by researchers at the University of Oxford in the UK found that no safety concerns were raised in the study of 1,070 participants.

Video Player is loading.
Current Time 0:05
Duration 0:52
Loaded: 85.85%
Stream Type LIVE
Remaining Time 0:47
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • default, selected

    Following up first doses of the AstraZeneca or Pfizer vaccines with second doses of the Moderna or Novavax jabs generates robust immune response against Covid-19, according to a study published in The Lancet journal.

    A team led by researchers at the University of Oxford in the UK found that no safety concerns were raised in the study of 1,070 participants.

    In addition, a significantly higher number of short-lived vaccine reactions were reported in volunteers who received a second dose of Moderna compared to those who received two doses of either AstraZeneca or Pfizer.

    Also watch: Covid booster shot, addition dose, vaccine for kids? Key expert panel meet today

    The study gains essence as the new variant of Omicron poses threat to become the dominant variant across the globe. It also supports flexible use of these vaccines, which is crucial to help rapidly deploy these vaccines, especially in low and middle-income countries.

    The study gains essence as the Omicron variant of coronavirus poses threat to become the dominant strain across the globe. It also supports flexible use of these vaccines, which is crucial to help rapidly deploy these vaccines, especially in low and middle-income countries.

    The LancetCovid 19 vaccine

    ADVERTISEMENT

    Up Next

    Mixing vaccines with AstraZeneca, Pfizer induces strong immune response: Lancet study

    Mixing vaccines with AstraZeneca, Pfizer induces strong immune response: Lancet study

    News Wrap | Sensex & Nifty Down; SBI Tanks; Fresh Allegations Vs SEBI Chief | September 6, 2024

    News Wrap | Sensex & Nifty Down; SBI Tanks; Fresh Allegations Vs SEBI Chief | September 6, 2024

    Parliamentary Panel May Summon SEBI Chief Madhabi Puri Buch Amid Allegations of Corruption

    Parliamentary Panel May Summon SEBI Chief Madhabi Puri Buch Amid Allegations of Corruption

    Linkin Park unveil new singer, announce album 7 years after lead singer's death

    Linkin Park unveil new singer, announce album 7 years after lead singer's death

    India Day Parade in New York: Sonakshi Sinha-Zaheer Iqbal’s special message

    India Day Parade in New York: Sonakshi Sinha-Zaheer Iqbal’s special message

    Vivo T3 Ultra 5G: First Look! Flagship Killer?

    Vivo T3 Ultra 5G: First Look! Flagship Killer?

    ADVERTISEMENT

    editorji-whatsApp

    More videos

    RG Kar News: স্বশরীরে আদালতে নয়, আরজি কর কাণ্ডে ধৃত সঞ্জয় রায়ের ভার্চুয়াল শুনানি হবে শুক্রবার

    RG Kar News: স্বশরীরে আদালতে নয়, আরজি কর কাণ্ডে ধৃত সঞ্জয় রায়ের ভার্চুয়াল শুনানি হবে শুক্রবার

    This Taiwan-Born Tech Whiz Is Helping US Counter China’s Military Advances

    This Taiwan-Born Tech Whiz Is Helping US Counter China’s Military Advances

    Olympian Rebecca Cheptegei Dies, Days After Being Set On Fire By Boyfriend

    Olympian Rebecca Cheptegei Dies, Days After Being Set On Fire By Boyfriend

    Sandip Ghosh: 'ও কিছু করেনি, কোনও কাগজপত্রও পাওয়া যায়নি', দাবি সন্দীপ ঘোষের স্ত্রীর

    Sandip Ghosh: 'ও কিছু করেনি, কোনও কাগজপত্রও পাওয়া যায়নি', দাবি সন্দীপ ঘোষের স্ত্রীর

    BCCI Board Secretory: আইসিসির দায়িত্বে জয় শাহ, বোর্ডের সচিব পদে কে! কবে ঠিক করবে বিসিসিআই

    BCCI Board Secretory: আইসিসির দায়িত্বে জয় শাহ, বোর্ডের সচিব পদে কে! কবে ঠিক করবে বিসিসিআই

    Sandeep Ghosh: RG কর মামলায় সন্দীপ ঘনিষ্ঠ প্রসূন চট্টোপাধ্যায়কে আটক করল ED

    Sandeep Ghosh: RG কর মামলায় সন্দীপ ঘনিষ্ঠ প্রসূন চট্টোপাধ্যায়কে আটক করল ED

    Sandip Ghosh: সন্দীপের বাড়ি থেকে শ্বশুরবাড়ি, সকাল থেকে লাগাতার ইডি হানা

    Sandip Ghosh: সন্দীপের বাড়ি থেকে শ্বশুরবাড়ি, সকাল থেকে লাগাতার ইডি হানা

    Aparajita Bill 2024: 'টেকনিক্যাল রিপোর্ট' না পাঠানোয় অপরাজিতা বিল আটকে, রাজ্যকে দায়ী করে জানাল রাজভবন

    Aparajita Bill 2024: 'টেকনিক্যাল রিপোর্ট' না পাঠানোয় অপরাজিতা বিল আটকে, রাজ্যকে দায়ী করে জানাল রাজভবন

    Goldman Sachs Recommends Selling SBI Shares, Lowers Target Price to ₹742

    Goldman Sachs Recommends Selling SBI Shares, Lowers Target Price to ₹742

    Cristiano Ronaldo: দু'দশকের কেরিয়ারে ৯০০ গোল, আন্তর্জাতিক ফুটবলে সর্বোচ্চ গোলদাতার রেকর্ড রোনাল্ডোর

    Cristiano Ronaldo: দু'দশকের কেরিয়ারে ৯০০ গোল, আন্তর্জাতিক ফুটবলে সর্বোচ্চ গোলদাতার রেকর্ড রোনাল্ডোর

    Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.